India Medical Device Approval Process: 2026

India medical device approval – Market is one of the fastest-growing globally, driven by increasing healthcare demands, technological advancements, and a large population. However, navigating the regulatory landscape for medical device approval in India can be complex due to stringent guidelines and evolving policies. This article provides a detailed, step-by-step overview of the medical device approval process in India, governed primarily by the Central Drugs Standard Control Organization (CDSCO) under the Medical Devices Rules (MDR), 2017.

Regulatory Framework: Medical Devices Rules, 2017

The Medical Devices Rules, 2017, effective from January 1, 2018, form the backbone of India’s medical device regulations. Administered by the CDSCO under the Ministry of Health and Family Welfare, these rules classify medical devices based on risk and outline requirements for manufacturing, importing, and marketing devices in India.

Classification of Medical Devices

Medical devices in India are classified into four risk-based categories:

• Class A: Low risk (e.g., thermometers, bandages)
• Class B: Low-moderate risk (e.g., hypodermic needles, suction equipment)
• Class C: Moderate-high risk (e.g., ventilators, orthopedic implants)
• Class D: High risk (e.g., pacemakers, heart valves)

This classification aligns with international standards, such as those of the Global Harmonization Task Force (GHTF) and International Medical Device Regulators Forum (IMDRF).

Key Regulatory Bodies

1. Central Drugs Standard Control Organization (CDSCO): Oversees the approval, licensing, and post-market surveillance of medical devices.
2. Drugs Controller General of India (DCGI): The head of CDSCO, responsible for final approvals.
3. Bureau of Indian Standards (BIS): Ensures compliance with Indian quality standards for certain devices.
4. State Licensing Authorities: Handle licenses for manufacturing low-risk devices (Class A and B).

Step-by-Step Approval Process

The approval process varies depending on whether the device is manufactured domestically or imported, and its risk classification. Below is a streamlined guide:

1. Device Classification and Registration

• Identify the Risk Class: Determine the device’s classification (A, B, C, or D) based on MDR 2017 guidelines.
• Registration on SUGAM Portal: Manufacturers and importers must register on the CDSCO’s online SUGAM portal (www.cdscoonline.gov.in) to obtain login credentials and initiate the approval process.

2. Quality Management System (QMS) Compliance

• For Class C and D devices, compliance with ISO 13485 (Quality Management System for Medical Devices) is mandatory.
• Manufacturers must submit QMS documentation, including design controls, risk management, and manufacturing processes, to the CDSCO.
• A notified body or authorized auditor verifies QMS compliance.

3. Technical Documentation

Applicants must prepare a comprehensive technical dossier, including:

• Device description and intended use
• Design and manufacturing details
• Clinical evaluation data (for Class C and D devices)
• Risk analysis and mitigation strategies
• Labeling and Instructions for Use (IFU)
• Stability and shelf-life data
• For imported devices, CE marking or US FDA approval may support the application but is not sufficient alone.

4. Application Submission

• For Manufacturers:
  • Class A and B Devices: Apply for a manufacturing license through the State Licensing Authority via the SUGAM portal. Approval is typically faster for these low-risk devices.
  • Class C and D Devices: Submit applications to the CDSCO for a manufacturing license, along with QMS certification and technical documentation.
• For Importers:
  • Obtain an Import License (Form MD-15) from the CDSCO.
  • Submit a Free Sale Certificate from the country of origin, ISO 13485 certification, and proof of compliance with international standards (e.g., CE marking).
  • Appoint an Authorized Indian Agent to represent the foreign manufacturer.

5. Clinical Evaluation and Testing

• Clinical Evaluation: For Class C and D devices, clinical data demonstrating safety and efficacy is required. If no clinical data exists for India, global clinical data may be accepted, subject to CDSCO approval.
• Testing: Devices may need to be tested at a CDSCO-approved laboratory or BIS-accredited facility to ensure compliance with Indian standards.

6. License Issuance

• Upon successful review, the CDSCO or State Licensing Authority issues:
  • Manufacturing License (Form MD-5 for Class A/B, Form MD-9 for Class C/D)
  • Import License (Form MD-15)
• Licenses are valid for 5 years and can be renewed.

7. Post-Market Surveillance

• Manufacturers and importers must report adverse events, conduct post-market surveillance, and maintain records as per MDR 2017.
• The CDSCO may conduct periodic inspections to ensure compliance.

Special Considerations

• Non-Notified Devices: Devices not listed in the CDSCO’s notified categories are currently unregulated but may require registration under the Voluntary Registration Scheme until they are officially notified.
• BIS Certification: Certain devices require BIS certification for quality and safety compliance.
• Labeling Requirements: Labels must include the device’s name, manufacturer’s details, batch number, and expiry date, adhering to MDR 2017 and BIS standards.
• Timeline: The approval process can take 6–12 months for Class C/D devices and 3–6 months for Class A/B devices, depending on documentation and testing requirements.

Challenges in the Approval Process

1. Complex Documentation: Preparing a comprehensive technical dossier can be time-consuming, especially for high-risk devices.
2. Evolving Regulations: Frequent updates to MDR 2017 require manufacturers to stay informed.
3. Testing Infrastructure: Limited CDSCO-approved testing facilities can cause delays.
4. Language Barriers: Documentation must be in English, and translations may be required for imported devices.

Recent Developments

• Expansion of Notified Devices: The CDSCO periodically updates the list of notified medical devices, increasing the scope of regulation.
• Digital Health Push: The Indian government is promoting digital health technologies, leading to streamlined processes for software-based medical devices.
• Make in India: Incentives for local manufacturing are encouraging domestic production, with relaxed licensing for Class A/B devices.

Tips for Success

1. Engage a Regulatory Consultant: Local expertise can simplify navigation of the CDSCO process.
2. Ensure Compliance Early: Align with ISO 13485 and Indian standards during product development.
3. Leverage Global Approvals: CE marking or FDA approval can expedite the review process.
4. Monitor Updates: Stay informed about changes to MDR 2017 and CDSCO guidelines.

Conclusion

The medical device approval process in India, governed by the MDR 2017 and overseen by the CDSCO, is designed to ensure safety and efficacy while fostering innovation. By understanding the classification, documentation, and licensing requirements, manufacturers and importers can successfully navigate this process. With India’s healthcare sector poised for growth, a clear understanding of the regulatory landscape is essential for market entry and compliance.

CONTACT US

Satish Mehra

(vsd consultant)

+918920964801

whatsapp or call us now

Consult Regulatory expert

familiar with Indian medical device laws.